Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 121

1.

No detection of CD4-independent human immunodeficiency virus 1 envelope glycoproteins in brain tissue of patients with or without neurological complications.

Quitadamo B, Peters PJ, Koch M, Luzuriaga K, Cheng-Mayer C, Clapham PR, Gonzalez-Perez MP.

Arch Virol. 2019 Feb;164(2):473-482. doi: 10.1007/s00705-018-4094-1. Epub 2018 Nov 10.

2.

Gp120 V5 Is Targeted by the First Wave of Sequential Neutralizing Antibodies in SHIVSF162P3N-Infected Rhesus Macaques.

Jia M, Lu H, Kong XP, Cheng-Mayer C, Wu X.

Viruses. 2018 May 16;10(5). pii: E262. doi: 10.3390/v10050262.

3.

Determinants of HIV-1 CD4-Independent Brain Adaptation.

Shakirzyanova M, Kong XP, Cheng-Mayer C.

J Acquir Immune Defic Syndr. 2017 Oct 1;76(2):209-218. doi: 10.1097/QAI.0000000000001478.

PMID:
28628526
4.

Adapting SHIVs In Vivo Selects for Envelope-Mediated Interferon-α Resistance.

Boyd DF, Sharma A, Humes D, Cheng-Mayer C, Overbaugh J.

PLoS Pathog. 2016 Jul 11;12(7):e1005727. doi: 10.1371/journal.ppat.1005727. eCollection 2016 Jul.

5.
6.

Distinct Compartmentalization in the CNS of SHIVKU-1-Infected Chinese Rhesus Macaque Is Associated With Severe Neuropathology.

Xiao Q, Li J, Yu Q, Bao R, Liu J, Liu H, Zhou L, Xian Q, Wang Y, Cheng-Mayer C, Wenzhe H, Zhuang K.

J Acquir Immune Defic Syndr. 2015 Dec 15;70(5):e168-71. doi: 10.1097/QAI.0000000000000839. No abstract available.

PMID:
26361175
7.

Fast disease progression in simian HIV-infected female macaque is accompanied by a robust local inflammatory innate immune and microbial response.

Ren W, Ma Y, Yang L, Gettie A, Salas J, Russell K, Blanchard J, Davidow A, Pei Z, Chang TL, Cheng-Mayer C.

AIDS. 2015 Jun 19;29(10):F1-8. doi: 10.1097/QAD.0000000000000711.

8.

A long-acting integrase inhibitor protects female macaques from repeated high-dose intravaginal SHIV challenge.

Andrews CD, Yueh YL, Spreen WR, St Bernard L, Boente-Carrera M, Rodriguez K, Gettie A, Russell-Lodrigue K, Blanchard J, Ford S, Mohri H, Cheng-Mayer C, Hong Z, Ho DD, Markowitz M.

Sci Transl Med. 2015 Jan 14;7(270):270ra4. doi: 10.1126/scitranslmed.3010298.

9.

Emergence of CD4 independence envelopes and astrocyte infection in R5 simian-human immunodeficiency virus model of encephalitis.

Zhuang K, Leda AR, Tsai L, Knight H, Harbison C, Gettie A, Blanchard J, Westmoreland S, Cheng-Mayer C.

J Virol. 2014 Aug;88(15):8407-20. doi: 10.1128/JVI.01237-14. Epub 2014 May 14.

10.

The number and genetic relatedness of transmitted/founder virus impact clinical outcome in vaginal R5 SHIVSF162P3N infection.

Tsai L, Tasovski I, Leda AR, Chin MP, Cheng-Mayer C.

Retrovirology. 2014 Mar 11;11:22. doi: 10.1186/1742-4690-11-22.

11.

Long-acting integrase inhibitor protects macaques from intrarectal simian/human immunodeficiency virus.

Andrews CD, Spreen WR, Mohri H, Moss L, Ford S, Gettie A, Russell-Lodrigue K, Bohm RP, Cheng-Mayer C, Hong Z, Markowitz M, Ho DD.

Science. 2014 Mar 7;343(6175):1151-4. doi: 10.1126/science.1248707. Epub 2014 Mar 4.

12.

Giant cell encephalitis and microglial infection with mucosally transmitted simian-human immunodeficiency virus SHIVSF162P3N in rhesus macaques.

Harbison C, Zhuang K, Gettie A, Blanchard J, Knight H, Didier P, Cheng-Mayer C, Westmoreland S.

J Neurovirol. 2014 Feb;20(1):62-72. doi: 10.1007/s13365-013-0229-z. Epub 2014 Jan 25.

13.

Generation of lineage-related, mucosally transmissible subtype C R5 simian-human immunodeficiency viruses capable of AIDS development, induction of neurological disease, and coreceptor switching in rhesus macaques.

Ren W, Mumbauer A, Gettie A, Seaman MS, Russell-Lodrigue K, Blanchard J, Westmoreland S, Cheng-Mayer C.

J Virol. 2013 Jun;87(11):6137-49. doi: 10.1128/JVI.00178-13. Epub 2013 Mar 20.

14.

Mucosal transmissibility, disease induction and coreceptor switching of R5 SHIVSF162P3N molecular clones in rhesus macaques.

Ren W, Mumbauer A, Zhuang K, Harbison C, Knight H, Westmoreland S, Gettie A, Blanchard J, Cheng-Mayer C.

Retrovirology. 2013 Jan 31;10:9. doi: 10.1186/1742-4690-10-9.

15.

Identification of interdependent variables that influence coreceptor switch in R5 SHIV(SF162P3N)-infected macaques.

Zhuang K, Finzi A, Toma J, Frantzell A, Huang W, Sodroski J, Cheng-Mayer C.

Retrovirology. 2012 Dec 13;9:106. doi: 10.1186/1742-4690-9-106.

16.

Efficient mucosal transmissibility but limited pathogenicity of R5 SHIV SF162P3N in Chinese-origin rhesus macaques.

Mumbauer A, Gettie A, Blanchard J, Cheng-Mayer C.

J Acquir Immune Defic Syndr. 2013 Apr 15;62(5):496-504. doi: 10.1097/QAI.0b013e31827f1c11.

17.

Pathogenic consequences of vaginal infection with CCR5-tropic simian-human immunodeficiency virus SHIVSF162P3N.

Shakirzyanova M, Tsai L, Ren W, Gettie A, Blanchard J, Cheng-Mayer C.

J Virol. 2012 Sep;86(17):9432-42. doi: 10.1128/JVI.00852-12. Epub 2012 Jun 27.

18.

Adoption of an "open" envelope conformation facilitating CD4 binding and structural remodeling precedes coreceptor switch in R5 SHIV-infected macaques.

Zhuang K, Finzi A, Tasca S, Shakirzyanova M, Knight H, Westmoreland S, Sodroski J, Cheng-Mayer C.

PLoS One. 2011;6(7):e21350. doi: 10.1371/journal.pone.0021350. Epub 2011 Jul 8.

19.

Delay of simian human immunodeficiency virus infection and control of viral replication in vaccinated macaques challenged in the presence of a topical microbicide.

Cheng-Mayer C, Huang Y, Gettie A, Tsai L, Ren W, Shakirzyanova M, Sina ST, Trunova N, Blanchard J, Jenkins LM, Lo Y, Schito ML, Appella E.

AIDS. 2011 Sep 24;25(15):1833-41. doi: 10.1097/QAD.0b013e32834a1d94.

20.

Coreceptor use in nonhuman primate models of HIV infection.

Sina ST, Ren W, Cheng-Mayer C.

J Transl Med. 2011 Jan 27;9 Suppl 1:S7. doi: 10.1186/1479-5876-9-S1-S7. Review.

21.

Effect of B-cell depletion on coreceptor switching in R5 simian-human immunodeficiency virus infection of rhesus macaques.

Tasca S, Zhuang K, Gettie A, Knight H, Blanchard J, Westmoreland S, Cheng-Mayer C.

J Virol. 2011 Apr;85(7):3086-94. doi: 10.1128/JVI.02150-10. Epub 2011 Jan 19.

22.
23.

Different tempo and anatomic location of dual-tropic and X4 virus emergence in a model of R5 simian-human immunodeficiency virus infection.

Ren W, Tasca S, Zhuang K, Gettie A, Blanchard J, Cheng-Mayer C.

J Virol. 2010 Jan;84(1):340-51. doi: 10.1128/JVI.01865-09.

24.

Human immunodeficiency virus type 1 nucleocapsid inhibitors impede trans infection in cellular and explant models and protect nonhuman primates from infection.

Wallace GS, Cheng-Mayer C, Schito ML, Fletcher P, Miller Jenkins LM, Hayashi R, Neurath AR, Appella E, Shattock RJ.

J Virol. 2009 Sep;83(18):9175-82. doi: 10.1128/JVI.00820-09. Epub 2009 Jul 8.

25.

Coreceptor switch in infection of nonhuman primates.

Cheng-Mayer C, Tasca S, Ho SH.

Curr HIV Res. 2009 Jan;7(1):30-8. Review.

PMID:
19149552
26.

The use of nonhuman primate models in HIV vaccine development.

Morgan C, Marthas M, Miller C, Duerr A, Cheng-Mayer C, Desrosiers R, Flores J, Haigwood N, Hu SL, Johnson RP, Lifson J, Montefiori D, Moore J, Robert-Guroff M, Robinson H, Self S, Corey L.

PLoS Med. 2008 Aug 12;5(8):e173. doi: 10.1371/journal.pmed.0050173. No abstract available.

27.

R5X4 viruses are evolutionary, functional, and antigenic intermediates in the pathway of a simian-human immunodeficiency virus coreceptor switch.

Tasca S, Ho SH, Cheng-Mayer C.

J Virol. 2008 Jul;82(14):7089-99. doi: 10.1128/JVI.00570-08. Epub 2008 May 14.

28.

Different mutational pathways to CXCR4 coreceptor switch of CCR5-using simian-human immunodeficiency virus.

Ho SH, Trunova N, Gettie A, Blanchard J, Cheng-Mayer C.

J Virol. 2008 Jun;82(11):5653-6. doi: 10.1128/JVI.00145-08. Epub 2008 Apr 2.

29.

Induction of potent local cellular immunity with low dose X4 SHIV(SF33A) vaginal exposure.

Tasca S, Tsai L, Trunova N, Gettie A, Saifuddin M, Bohm R, Chakrabarti L, Cheng-Mayer C.

Virology. 2007 Oct 10;367(1):196-211. Epub 2007 Jun 15.

30.

Coreceptor switch in R5-tropic simian/human immunodeficiency virus-infected macaques.

Ho SH, Tasca S, Shek L, Li A, Gettie A, Blanchard J, Boden D, Cheng-Mayer C.

J Virol. 2007 Aug;81(16):8621-33. Epub 2007 May 30.

31.

Efficient repeated low-dose intravaginal infection with X4 and R5 SHIVs in rhesus macaque: implications for HIV-1 transmission in humans.

Tsai L, Trunova N, Gettie A, Mohri H, Bohm R, Saifuddin M, Cheng-Mayer C.

Virology. 2007 May 25;362(1):207-16. Epub 2007 Jan 29.

32.

Recombinant extracellular domains of tetraspanin proteins are potent inhibitors of the infection of macrophages by human immunodeficiency virus type 1.

Ho SH, Martin F, Higginbottom A, Partridge LJ, Parthasarathy V, Moseley GW, Lopez P, Cheng-Mayer C, Monk PN.

J Virol. 2006 Jul;80(13):6487-96.

33.

Progestin-based contraceptive suppresses cellular immune responses in SHIV-infected rhesus macaques.

Trunova N, Tsai L, Tung S, Schneider E, Harouse J, Gettie A, Simon V, Blanchard J, Cheng-Mayer C.

Virology. 2006 Aug 15;352(1):169-77. Epub 2006 May 30.

34.

A CCR5-tropic simian-HIV molecular clone capable of inducing AIDS in rhesus macaques.

Hsu M, Ho SH, Balfe P, Gettie A, Harouse J, Blanchard J, Cheng-Mayer C.

J Acquir Immune Defic Syndr. 2005 Dec 1;40(4):383-7.

PMID:
16280691
35.

Safety and distribution of cellulose acetate 1,2-benzenedicarboxylate (CAP), a candidate anti-HIV microbicide in rhesus macaques.

Ratterree M, Gettie A, Williams V, Malenbaum S, Neurath AR, Cheng-Mayer C, Blanchard J.

AIDS. 2005 Oct 14;19(15):1595-9.

PMID:
16184028
36.

Cellulose acetate 1,2-benzenedicarboxylate protects against challenge with pathogenic X4 and R5 simian/human immunodeficiency virus.

Boadi T, Schneider E, Chung S, Tsai L, Gettie A, Ratterree M, Blanchard J, Neurath AR, Cheng-Mayer C.

AIDS. 2005 Oct 14;19(15):1587-94.

PMID:
16184027
37.
38.

HLA-A2 down-regulation on primary human macrophages infected with an M-tropic EGFP-tagged HIV-1 reporter virus.

Brown A, Gartner S, Kawano T, Benoit N, Cheng-Mayer C.

J Leukoc Biol. 2005 Sep;78(3):675-85. Epub 2005 Jul 6.

PMID:
16000390
39.

The V1, V2, and V3 regions of the human immunodeficiency virus type 1 envelope differentially affect the viral phenotype in an isolate-dependent manner.

Saunders CJ, McCaffrey RA, Zharkikh I, Kraft Z, Malenbaum SE, Burke B, Cheng-Mayer C, Stamatatos L.

J Virol. 2005 Jul;79(14):9069-80.

40.
41.

Multiple human immunodeficiency virus type 1 Nef functions contribute to efficient replication in primary human macrophages.

Brown A, Moghaddam S, Kawano T, Cheng-Mayer C.

J Gen Virol. 2004 Jun;85(Pt 6):1463-9.

PMID:
15166429
42.

Expansion of quasispecies diversity but no evidence for adaptive evolution of SHIV during rapid serial transfers among seronegative macaques.

Balfe P, Shapiro S, Hsu M, Buckner C, Harouse JM, Cheng-Mayer C.

Virology. 2004 Jan 5;318(1):267-79.

43.

Induction of simian AIDS in infant rhesus macaques infected with CCR5- or CXCR4-utilizing simian-human immunodeficiency viruses is associated with distinct lesions of the thymus.

Reyes RA, Canfield DR, Esser U, Adamson LA, Brown CR, Cheng-Mayer C, Gardner MB, Harouse JM, Luciw PA.

J Virol. 2004 Feb;78(4):2121-30.

44.

Antigenic variations in the CD4 induced sites of the CCR5-tropic, pathogenic SHIVsf162p3 gp120 variants.

Hsu M, Buckner C, Harouse J, Gettie A, Blanchard J, Robinson JE, Cheng-Mayer C.

J Med Primatol. 2003 Aug;32(4-5):211-7.

PMID:
14498981
45.

CD8+ T cell-mediated CXC chemokine receptor 4-simian/human immunodeficiency virus suppression in dually infected rhesus macaques.

Harouse JM, Buckner C, Gettie A, Fuller R, Bohm R, Blanchard J, Cheng-Mayer C.

Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10977-82. Epub 2003 Sep 8.

46.

Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles.

Hsu M, Zhang J, Flint M, Logvinoff C, Cheng-Mayer C, Rice CM, McKeating JA.

Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7271-6. Epub 2003 May 21.

47.

Susceptibility of mink (Mustera vision)-derived cells to replication by human immunodeficiency virus type 1.

Koito A, Kameyama Y, Cheng-Mayer C, Matsushita S.

J Virol. 2003 May;77(9):5109-17.

48.

A truncated form of Nef selected during pathogenic reversion of simian immunodeficiency virus SIVmac239Deltanef increases viral replication.

Chakrabarti LA, Metzner KJ, Ivanovic T, Cheng H, Louis-Virelizier J, Connor RI, Cheng-Mayer C.

J Virol. 2003 Jan;77(2):1245-56.

50.

Infection of macaques with a molecular clone, SHIVSF33A2, provides evidence for tissue specific variants.

Buckner CM, Gettie A, Tan RC, Eshetu T, Ratterree M, Blanchard J, Cheng-Mayer C, Harouse JM.

J Med Primatol. 2002 Aug;31(4-5):164-70.

PMID:
12390538

Supplemental Content

Loading ...
Support Center